In KitV558Δ/+ mouse GIST model, anti-CD40 antibody activated tumor-associated macrophages (TAMs) to produce TNFα, and enhanced the antitumor activity of imatinib [199]. The gene discussed is CD40; the disease is gastrointestinal stromal tumor.